TY - JOUR
T1 - Case report
T2 - Metastatic cutaneous squamous cell carcinoma in an African American Female
AU - Harb, Jennifer N.
AU - Owens, Alexandra L.
AU - Potter, Kathryn Mooneyham
AU - Montuno, Michael
AU - De Jesus, Reordan O.
AU - Konda, Sailesh
PY - 2017/1
Y1 - 2017/1
N2 - Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1% to 2% of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31%, compared with only 4% in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.
AB - Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1% to 2% of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31%, compared with only 4% in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.
UR - http://www.scopus.com/inward/record.url?scp=85028917433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028917433&partnerID=8YFLogxK
M3 - Article
C2 - 28914954
AN - SCOPUS:85028917433
SN - 1545-9616
VL - 16
SP - 81
EP - 84
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 1
ER -